H2S

Optimal result: 0 – 3 ppm

Elevated levels of hydrogen sulfide are indicative of excess hydrogen sulfide.

Excess hydrogen sulfide is a condition in which sulfate-reducing organisms produce high amounts of hydrogen sulfide in the gut. Excess hydrogen sulfide was undetectable by traditional breath testing prior to trio-smart, and patients with excess hydrogen sulfide may have appeared "normal" on previous breath tests. 

Elevated hydrogen sulfide levels predict more severe diarrhea, and the level of hydrogen sulfide is correlated with the degree of diarrhea. 

Trio-smart measures a third fermented gas, hydrogen sulfide (H2S). Which is produced by sulfate-reducing bacteria utilizing H2 to produce H2S. Clinical trials have noted that H2S is associated with diarrhea in patients. In a 2021 study, it was found that healthy subjects had H2S levels of <3.00 ppm. Levels of hydrogen sulfide ≥3.00 ppm are associated with diarrhea and indicative of excess hydrogen sulfide. Higher levels of hydrogen sulfide predict more severe diarrhea.

Hydrogen sulfide is produced when sulfate-reducing organisms consume hydrogen.

Hydrogen sulfide levels are considered abnormal if they reach ≥3ppm (parts per million) at any point during the breath test.

Trio-smart measures a third fermented gas, hydrogen sulfide (H2S). Which is produced by sulfate-reducing bacteria utilizing H2 to produce H2S. Clinical trials have noted that H2S is associated with diarrhea in patients. In a 2021 study, it was found that healthy subjects had H2S levels of <3.00 ppm. Levels of hydrogen sulfide ≥3.00 ppm are associated with diarrhea and indicative of excess hydrogen sulfide. Higher levels of hydrogen sulfide predict more severe diarrhea.

The "Expected" threshold for H2S is 3.00 ppm. Levels of H2S ≥3.00 ppm at any point during the breath test are considered excess and are associated with diarrhea. A 2022 study demonstrated that in diarrheal IBS patients, H2S ≥2.00 ppm was notably distinguishable from patients with constipation IBS, and was associated with greater H2S- producing bacteria in the gut. For patients with a level ≥ 2.00 ppm, it is recommended to use good clinical judgment to determine the merit of treatment for this result.

References:

Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017 May;112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21. PMID: 28323273; PMCID: PMC5418558.

Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020 Feb;115(2):165-178. doi: 10.14309/ajg.0000000000000501. PMID: 32023228.

Singer-Englar, Tahli, Ali Rezaie, Kapil Gupta, Nipaporn Pichetshote, Rashin Sedighi, Eugenia A. Lin, Kathleen Shari Chua and Mark Pimentel. “Sa1219 - Validation of a 4-Gas Device for Breath Testing in the Determination of Small Intestinal Bacterial Overgrowth.” Gastroenterology 154 (2018): n. pag.

Villanueva-Millan MJ, Leite G, Wang J, Morales W, Parodi G, Pimentel ML, Barlow GM, Mathur R, Rezaie A, Sanchez M, Ayyad S, Cohrs D, Chang C, Rashid M, Hosseini A, Fiorentino A, Weitsman S, Chuang B, Chang B, Pichetshote N, Pimentel M. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes. Am J Gastroenterol. 2022 Dec 1;117(12):2055-2066. doi: 10.14309/ajg.0000000000001997. Epub 2022 Sep 6. PMID: 36114762; PMCID: PMC9722381.

Villanueva-Millan MJ, Leite G, Wang J, Morales W, Parodi G, Pimentel ML, Barlow GM, Mathur R, Rezaie A, Sanchez M, Ayyad S, Cohrs D, Chang C, Rashid M, Hosseini A, Fiorentino A, Weitsman S, Chuang B, Chang B, Pichetshote N, Pimentel M. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes. Am J Gastroenterol. 2022 Dec 1;117(12):2055-2066. doi: 10.14309/ajg.0000000000001997. Epub 2022 Sep 6. PMID: 36114762; PMCID: PMC9722381.

H2S
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond H2S — 10,000+ markers explained
One H2S result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro